2024-09-012025-08-312025-08-31false10176339PETER RABBIT NURSERY LIMITED2026-05-28falseiso4217:GBPxbrli:pure101763392024-08-31101763392025-08-31101763392024-09-012025-08-31101763392023-07-31101763392024-08-31101763392023-08-012024-08-3110176339bus:SmallEntities2024-09-012025-08-3110176339bus:AuditExempt-NoAccountantsReport2024-09-012025-08-3110176339bus:AbridgedAccounts2024-09-012025-08-3110176339bus:PrivateLimitedCompanyLtd2024-09-012025-08-3110176339core:WithinOneYear2025-08-3110176339core:AfterOneYear2025-08-3110176339core:WithinOneYear2024-08-3110176339core:AfterOneYear2024-08-3110176339core:ShareCapital2025-08-3110176339core:SharePremium2025-08-3110176339core:RevaluationReserve2025-08-3110176339core:OtherReservesSubtotal2025-08-3110176339core:RetainedEarningsAccumulatedLosses2025-08-3110176339core:ShareCapital2024-08-3110176339core:SharePremium2024-08-3110176339core:RevaluationReserve2024-08-3110176339core:OtherReservesSubtotal2024-08-3110176339core:RetainedEarningsAccumulatedLosses2024-08-3110176339core:LandBuildings2025-08-3110176339core:PlantMachinery2025-08-3110176339core:Vehicles2025-08-3110176339core:FurnitureFittings2025-08-3110176339core:OfficeEquipment2025-08-3110176339core:NetGoodwill2025-08-3110176339core:IntangibleAssetsOtherThanGoodwill2025-08-3110176339core:ListedExchangeTraded2025-08-3110176339core:UnlistedNon-exchangeTraded2025-08-3110176339core:LandBuildings2024-08-3110176339core:PlantMachinery2024-08-3110176339core:Vehicles2024-08-3110176339core:FurnitureFittings2024-08-3110176339core:OfficeEquipment2024-08-3110176339core:NetGoodwill2024-08-3110176339core:IntangibleAssetsOtherThanGoodwill2024-08-3110176339core:ListedExchangeTraded2024-08-3110176339core:UnlistedNon-exchangeTraded2024-08-3110176339core:LandBuildings2024-09-012025-08-3110176339core:PlantMachinery2024-09-012025-08-3110176339core:Vehicles2024-09-012025-08-3110176339core:FurnitureFittings2024-09-012025-08-3110176339core:OfficeEquipment2024-09-012025-08-3110176339core:NetGoodwill2024-09-012025-08-3110176339core:IntangibleAssetsOtherThanGoodwill2024-09-012025-08-3110176339core:ListedExchangeTraded2024-09-012025-08-3110176339core:UnlistedNon-exchangeTraded2024-09-012025-08-3110176339core:MoreThanFiveYears2024-09-012025-08-3110176339core:Non-currentFinancialInstruments2025-08-3110176339core:Non-currentFinancialInstruments2024-08-3110176339dpl:CostSales2024-09-012025-08-3110176339dpl:DistributionCosts2024-09-012025-08-3110176339core:LandBuildings2024-09-012025-08-3110176339core:PlantMachinery2024-09-012025-08-3110176339core:Vehicles2024-09-012025-08-3110176339core:FurnitureFittings2024-09-012025-08-3110176339core:OfficeEquipment2024-09-012025-08-3110176339dpl:AdministrativeExpenses2024-09-012025-08-3110176339core:NetGoodwill2024-09-012025-08-3110176339core:IntangibleAssetsOtherThanGoodwill2024-09-012025-08-3110176339dpl:GroupUndertakings2024-09-012025-08-3110176339dpl:ParticipatingInterests2024-09-012025-08-3110176339dpl:GroupUndertakingscore:ListedExchangeTraded2024-09-012025-08-3110176339core:ListedExchangeTraded2024-09-012025-08-3110176339dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-09-012025-08-3110176339core:UnlistedNon-exchangeTraded2024-09-012025-08-3110176339dpl:CostSales2023-08-012024-08-3110176339dpl:DistributionCosts2023-08-012024-08-3110176339core:LandBuildings2023-08-012024-08-3110176339core:PlantMachinery2023-08-012024-08-3110176339core:Vehicles2023-08-012024-08-3110176339core:FurnitureFittings2023-08-012024-08-3110176339core:OfficeEquipment2023-08-012024-08-3110176339dpl:AdministrativeExpenses2023-08-012024-08-3110176339core:NetGoodwill2023-08-012024-08-3110176339core:IntangibleAssetsOtherThanGoodwill2023-08-012024-08-3110176339dpl:GroupUndertakings2023-08-012024-08-3110176339dpl:ParticipatingInterests2023-08-012024-08-3110176339dpl:GroupUndertakingscore:ListedExchangeTraded2023-08-012024-08-3110176339core:ListedExchangeTraded2023-08-012024-08-3110176339dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-08-012024-08-3110176339core:UnlistedNon-exchangeTraded2023-08-012024-08-3110176339core:NetGoodwill2025-08-3110176339core:IntangibleAssetsOtherThanGoodwill2025-08-3110176339core:LandBuildings2025-08-3110176339core:PlantMachinery2025-08-3110176339core:Vehicles2025-08-3110176339core:FurnitureFittings2025-08-3110176339core:OfficeEquipment2025-08-3110176339core:AfterOneYear2025-08-3110176339core:WithinOneYear2025-08-3110176339core:ListedExchangeTraded2025-08-3110176339core:UnlistedNon-exchangeTraded2025-08-3110176339core:ShareCapital2025-08-3110176339core:SharePremium2025-08-3110176339core:RevaluationReserve2025-08-3110176339core:OtherReservesSubtotal2025-08-3110176339core:RetainedEarningsAccumulatedLosses2025-08-3110176339core:NetGoodwill2024-08-3110176339core:IntangibleAssetsOtherThanGoodwill2024-08-3110176339core:LandBuildings2024-08-3110176339core:PlantMachinery2024-08-3110176339core:Vehicles2024-08-3110176339core:FurnitureFittings2024-08-3110176339core:OfficeEquipment2024-08-3110176339core:AfterOneYear2024-08-3110176339core:WithinOneYear2024-08-3110176339core:ListedExchangeTraded2024-08-3110176339core:UnlistedNon-exchangeTraded2024-08-3110176339core:ShareCapital2024-08-3110176339core:SharePremium2024-08-3110176339core:RevaluationReserve2024-08-3110176339core:OtherReservesSubtotal2024-08-3110176339core:RetainedEarningsAccumulatedLosses2024-08-3110176339core:NetGoodwill2023-07-3110176339core:IntangibleAssetsOtherThanGoodwill2023-07-3110176339core:LandBuildings2023-07-3110176339core:PlantMachinery2023-07-3110176339core:Vehicles2023-07-3110176339core:FurnitureFittings2023-07-3110176339core:OfficeEquipment2023-07-3110176339core:AfterOneYear2023-07-3110176339core:WithinOneYear2023-07-3110176339core:ListedExchangeTraded2023-07-3110176339core:UnlistedNon-exchangeTraded2023-07-3110176339core:ShareCapital2023-07-3110176339core:SharePremium2023-07-3110176339core:RevaluationReserve2023-07-3110176339core:OtherReservesSubtotal2023-07-3110176339core:RetainedEarningsAccumulatedLosses2023-07-3110176339core:AfterOneYear2024-09-012025-08-3110176339core:WithinOneYear2024-09-012025-08-3110176339core:Non-currentFinancialInstrumentscore:CostValuation2024-09-012025-08-3110176339core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-09-012025-08-3110176339core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-09-012025-08-3110176339core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-09-012025-08-3110176339core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-09-012025-08-3110176339core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-09-012025-08-3110176339core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-09-012025-08-3110176339core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-09-012025-08-3110176339core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-09-012025-08-3110176339core:Non-currentFinancialInstrumentscore:CostValuation2025-08-3110176339core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-08-3110176339core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-08-3110176339core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-08-3110176339core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-08-3110176339core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-08-3110176339core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-08-3110176339core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-08-3110176339core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-08-3110176339core:Non-currentFinancialInstrumentscore:CostValuation2024-08-3110176339core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-08-3110176339core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-08-3110176339core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-08-3110176339core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-08-3110176339core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-08-3110176339core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-08-3110176339core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-08-3110176339core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-08-3110176339bus:Director12024-09-012025-08-3110176339bus:Director22024-09-012025-08-31

PETER RABBIT NURSERY LIMITED

Registered Number
10176339
(England and Wales)

Unaudited Financial Statements for the Year ended
31 August 2025

PETER RABBIT NURSERY LIMITED
Company Information
for the year from 1 September 2024 to 31 August 2025

Directors

FREETH, Claire Elizabeth
FRENCH, Laura

Registered Address

Winterfold Birch Tree Lane
West Chiltington
Pulborough
RH20 2RG

Registered Number

10176339 (England and Wales)
PETER RABBIT NURSERY LIMITED
Statement of Financial Position
31 August 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets34,0415,957
4,0415,957
Current assets
Debtors10,8076,736
Cash at bank and on hand111,21876,242
122,02582,978
Creditors amounts falling due within one year4(13,156)(19,143)
Net current assets (liabilities)108,86963,835
Total assets less current liabilities112,91069,792
Creditors amounts falling due after one year(37,503)(26,443)
Net assets75,40743,349
Capital and reserves
Called up share capital100100
Profit and loss account75,30743,249
Shareholders' funds75,40743,349
The financial statements were approved and authorised for issue by the Board of Directors on 28 May 2026, and are signed on its behalf by:
FRENCH, Laura
Director
Registered Company No. 10176339
PETER RABBIT NURSERY LIMITED
Notes to the Financial Statements
for the year ended 31 August 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Turnover policy
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Government grants or assistance
Grants received towards revenue expenditure are released to the income statement as the related expenditure is incurred.
2.Average number of employees

20252024
Average number of employees during the year65
3.Tangible fixed assets

Total

£
Cost or valuation
At 01 September 2410,211
At 31 August 2510,211
Depreciation and impairment
At 01 September 244,255
Charge for year1,915
At 31 August 256,170
Net book value
At 31 August 254,041
At 31 August 245,957
4.Creditors: amounts due within one year

2025

2024

££
Taxation and social security12,19616,506
Other creditors-1,677
Accrued liabilities and deferred income960960
Total13,15619,143
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
5.Operating lease commitments
At 31 August 2025, the company had total commitments under non-cancellable operating leases over the remaining life of those leases. 2025 2024 Less Than 1 Year £12,000 £12,000 More Than 1 Year £13,000 £25,000